BioLargo Inc

BioLargo insider buys reveal executive confidence amid volatile price swings—explore how option exercises, PFAS tech and revenue targets could shape the stock’s future.

BioLargo’s insider option buying signals confidence in its PFAS tech amid steep stock decline and regulatory tailwinds, yet highlights earnings risks and volatility.